Results 151 to 160 of about 46,348 (289)

Relationship between Macular Thickness and the Ratio of Vascular Endothelial Growth Factor to Its Soluble Receptor 1 in Non-Proliferative Diabetic Retinopathy

open access: yesمجله دانشکده پزشکی اصفهان, 2012
Background: The goal of this study was to determine the ratio of vascular endothelial growth factor (VEGF) to soluble VEGF receptor 1 (SVEGFR1) in aqueous humor of patients with non-proliferative diabetic retinopathy (NPDR).
Zahra Hasanpour   +4 more
doaj  

RURANET++: An Unsupervised Learning Method for Diabetic Macular Edema Based on SCSE Attention Mechanisms and Dynamic Multi-Projection Head Clustering [PDF]

open access: yesarXiv
Diabetic Macular Edema (DME), a prevalent complication among diabetic patients, constitutes a major cause of visual impairment and blindness. Although deep learning has achieved remarkable progress in medical image analysis, traditional DME diagnosis still relies on extensive annotated data and subjective ophthalmologist assessments, limiting practical
arxiv  

Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema [PDF]

open access: bronze, 2007
J. Fernando Arévalo   +8 more
openalex   +1 more source

Natural products targeting tumour angiogenesis

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 10, Page 2094-2136, May 2025.
Abstract Tumour angiogenesis is the formation of new blood vessels to support the growth of a tumour. This process is critical for tumour progression and metastasis, making it an attractive approach to cancer therapy. Natural products derived from plants, animals or microorganisms exert anti‐angiogenic properties and can be used to inhibit tumour ...
Xiaohua Lu   +2 more
wiley   +1 more source

Reproducibility of Macular Thickness and Volume Using Zeiss Optical Coherence Tomography in Patients with Diabetic Macular Edema [PDF]

open access: green, 2007
Magdalena G. Krzystolik   +15 more
openalex   +1 more source

Ranibizumab with luseogliflozin in type 2 diabetes with diabetic macular oedema: A randomised clinical trial

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 5, Page 2473-2484, May 2025.
Abstract Aims Anti‐vascular endothelial growth factor (VEGF) therapy is the standard treatment for diabetic macular oedema (DMO); however, unmet needs remain. This study aimed to assess the effectiveness of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in treating DMO.
Ryoichi Ishibashi   +12 more
wiley   +1 more source

Multiple Laser Photocoagulation Treatments for the Management of Diabetic Macular Edema [PDF]

open access: yes, 2006
The purpose of this study was to evaluate functional and funduscopic outcomes amongst patients receiving multiple treatments with macular laser photocoagulation for clinically significant diabetic macular edema.
Vora, Sadhna
core   +1 more source

The quality, accuracy and appropriateness of UK optometric age‐related macular degeneration referrals

open access: yesOphthalmic and Physiological Optics, Volume 45, Issue 3, Page 799-809, May 2025.
Abstract Purpose Little is known about the quality of optometrists' referrals to secondary care for neovascular age‐related macular degeneration (nAMD), despite the need for timely intervention. We analysed the content and accuracy of optometrists' referrals for nAMD.
Corinne Fulcher   +2 more
wiley   +1 more source

The Management of Two Cases with Retinal Arterial Macroaneurysm by Anti-Vascular Endothelial Growth Factor

open access: yesCase Reports in Ophthalmology
Introduction: We report on one case of age-related macular degeneration and one case of diabetic macular edema with concomitant retinal arterial macroaneurysm (RAM) that were treated with anti-vascular endothelial growth factor (VEGF) intravitreal ...
Michiko Takamiya
doaj   +1 more source

Home - About - Disclaimer - Privacy